Drug Manufacturers’ 340B Restrictions Generate New Round Of Media Scrutiny & Criticism

August 16, 2023340B, 340B ESP, Drug Manufacturer Restrictions, News Updates

In the past week, no less than three articles have called attention to the restrictions drug manufacturers have imposed to evade their legal responsibility to honor 340B program prescription discounts — as well as the impact those restrictions have had on 340B-eligible nonprofit entities’ ability to serve their patients and communities. “Don’t believe drug companies: … Read More